de Groot PG - Search Results

1

FRETS-VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura.

Groot E, Hulstein JJ, Rison CN, de Groot PG, Fijnheer R. Groot E, et al. Among authors: de groot pg. J Thromb Haemost. 2006 Mar;4(3):698-9. doi: 10.1111/j.1538-7836.2005.01767.x. J Thromb Haemost. 2006. PMID: 16460463 Free article. No abstract available.

2

Regulation of von Willebrand factor-platelet interactions.

Lenting PJ, Pegon JN, Groot E, de Groot PG. Lenting PJ, et al. Among authors: groot e, de groot pg. Thromb Haemost. 2010 Sep;104(3):449-55. doi: 10.1160/TH09-11-0777. Epub 2010 Jun 10. Thromb Haemost. 2010. PMID: 20539912 Review.

3

Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment.

Minnema MC, Fijnheer R, De Groot PG, Lokhorst HM. Minnema MC, et al. Among authors: de groot pg. J Thromb Haemost. 2003 Mar;1(3):445-9. doi: 10.1046/j.1538-7836.2003.00083.x. J Thromb Haemost. 2003. PMID: 12871448 Free article.

4

Truncation of ADAMTS13 by Plasmin Enhances Its Activity in Plasma.

Clark CC, Mebius MM, de Maat S, Tielens AGM, de Groot PG, Urbanus RT, Fijnheer R, Hazenberg BPC, van Hellemond JJ, Maas C. Clark CC, et al. Among authors: de groot pg, de maat s. Thromb Haemost. 2018 Mar;118(3):471-479. doi: 10.1055/s-0038-1627460. Epub 2018 Mar 13. Thromb Haemost. 2018. PMID: 29534248

5

ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria.

de Mast Q, Groot E, Asih PB, Syafruddin D, Oosting M, Sebastian S, Ferwerda B, Netea MG, de Groot PG, van der Ven AJ, Fijnheer R. de Mast Q, et al. Among authors: groot e, de groot pg. Am J Trop Med Hyg. 2009 Mar;80(3):492-8. Am J Trop Med Hyg. 2009. PMID: 19270304

6

The presence of active von Willebrand factor under various pathological conditions.

Groot E, de Groot PG, Fijnheer R, Lenting PJ. Groot E, et al. Among authors: de groot pg. Curr Opin Hematol. 2007 May;14(3):284-9. doi: 10.1097/MOH.0b013e3280dce531. Curr Opin Hematol. 2007. PMID: 17414220 Review.

7

Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria.

de Mast Q, Groot E, Lenting PJ, de Groot PG, McCall M, Sauerwein RW, Fijnheer R, van der Ven A. de Mast Q, et al. Among authors: groot e, de groot pg. J Infect Dis. 2007 Aug 15;196(4):622-8. doi: 10.1086/519844. Epub 2007 Jul 10. J Infect Dis. 2007. PMID: 17624850

8

Indications for a protective function of beta2-glycoprotein I in thrombotic thrombocytopenic purpura.

Du VX, van Os G, Kremer Hovinga JA, Dienava-Verdoold I, Wollersheim J, Ruggeri ZM, Fijnheer R, de Groot PG, de Laat B. Du VX, et al. Among authors: de laat b, de groot pg. Br J Haematol. 2012 Oct;159(1):94-103. doi: 10.1111/bjh.12004. Epub 2012 Aug 9. Br J Haematol. 2012. PMID: 22881339 Free article.

9

Keeping von Willebrand Factor under Control: Alternatives for ADAMTS13.

Tersteeg C, Fijnheer R, Pasterkamp G, de Groot PG, Vanhoorelbeke K, de Maat S, Maas C. Tersteeg C, et al. Among authors: de groot pg, de maat s. Semin Thromb Hemost. 2016 Feb;42(1):9-17. doi: 10.1055/s-0035-1564838. Epub 2015 Nov 23. Semin Thromb Hemost. 2016. PMID: 26595154 Review.

10

Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus.

Fijnheer R, Horbach DA, Donders RC, Vilé H, von Oort E, Nieuwenhuis HK, Gmelig-Meijling FH, de Groot PG, Derksen RH. Fijnheer R, et al. Among authors: de groot pg. Thromb Haemost. 1996 Oct;76(4):514-7. Thromb Haemost. 1996. PMID: 8902988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

518 results

Search Page